| Betterchem |
|
|
| FDA approval activities
for this prescription drug:
Xalatan (latanoprost) ophthalmic solution, 0.005%, Pharmacia & Upjohn Company NDA 20-597/S28 & S29 7/14/03 7/28/03 Xalatan (latanoprost) ophthalmic solution, 0.005%, Pharmacia & Upjohn Company NDA 20-597/S-025 8/26/02 8/30/02 8/26/02 Xalatan (latanoprost) ophthalmic solution, 0.005%, Pharmacia & Upjohn Company NDA 20-597/S-023 11/26/01 4/28/03 Xalatan (latanoprost) ophthalmic solution, 0.005%, Pharmacia & Upjohn Company NDA 20-597/S-019 8/8/01 4/28/03 Xalatan (latanoprost) ophthalmic solution, 0.005%, Pharmacia & Upjohn Company NDA 20-597/S-010 |
© 2007 Betterchem Corp.
|